Table 1 Baseline characteristics of the patients at the beginning of the study

From: Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

Parameters

Imidapril (n=42)

Candesartan (n=42)

Age (years)

56.8±9.6

56.6±10.1

Gender (M/F)

19/23

20/22

BMI (kg m−2)

27.4±1.49

27.6±1.51

SBP (mm Hg)

150.2±8.4

150.7±8.2

DBP (mm Hg)

98.6±5.2

98.9±4.9

FPG (mg dl−1)

92.3±8.4

91.8±8.1

FPI (μIU ml−1)

14.3±3.7

14.1±3.8

TG (mg dl−1)

168.5±32.4

172.2±33.9

HDL-C (mg dl−1)

42.4±5.6

42.1±5.3

TC (mg dl−1)

191.1±13.7

190.8±13.5

Creatinine clearance (ml min−1)

92.2±11.9

98.9±12.1

Duration of hypertension (years)

8.5±2.8

8.4±3.1

  1. Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; F, female; FPG, fasting plasma glucose; FPI, fasting plasma insulin; HDL-C: high density lipoprotein cholesterol; M, male; SBP, systolic blood pressure; TC: total cholesterol; TG, triglycerides.
  2. P not significant.
Back to article page